SIMILAR PATTERNS OF AMINO ACIDS FOR 2X0Y_A_X0TA1625

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ar1 CYTOCHROME C OXIDASE

(Paracoccus
denitrificans)
PF00116
(COX2)
PF02790
(COX2_TM)
5 ASP B 130
VAL B 132
TYR B 127
VAL B 163
VAL B   3
None
1.46A 2x0yA-1ar1B:
undetectable
2x0yA-1ar1B:
18.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wxx HYPOTHETICAL PROTEIN
TTHA1280


(Thermus
thermophilus)
PF10672
(Methyltrans_SAM)
5 VAL A 184
TYR A 113
VAL A 118
VAL A 162
ASP A 149
None
1.26A 2x0yA-1wxxA:
undetectable
2x0yA-1wxxA:
20.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2im9 HYPOTHETICAL PROTEIN

(Legionella
pneumophila)
PF07313
(DUF1460)
5 ASP A 119
VAL A 122
ASN A 165
VAL A 242
ASP A 288
None
0.95A 2x0yA-2im9A:
undetectable
2x0yA-2im9A:
18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iut DNA TRANSLOCASE FTSK

(Pseudomonas
aeruginosa)
PF01580
(FtsK_SpoIIIE)
5 ASP A 498
VAL A 476
ASN A 477
VAL A 701
ASP A 698
None
1.46A 2x0yA-2iutA:
undetectable
2x0yA-2iutA:
21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j3h NADP-DEPENDENT
OXIDOREDUCTASE P1


(Arabidopsis
thaliana)
PF00107
(ADH_zinc_N)
PF16884
(ADH_N_2)
5 ASP A 204
VAL A 184
TYR A 182
THR A 158
ASN A 244
None
1.24A 2x0yA-2j3hA:
undetectable
2x0yA-2j3hA:
20.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2j4g HYALURONOGLUCOSAMINI
DASE


(Bacteroides
thetaiotaomicron)
PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase)
7 ASP A 242
TYR A 282
THR A 310
VAL A 314
ASN A 339
VAL A 342
ASP A 344
NB1  A1590 (-3.7A)
NB1  A1590 (-3.8A)
NB1  A1590 (-3.9A)
None
NB1  A1590 (-3.6A)
NB1  A1590 ( 4.9A)
NB1  A1590 ( 3.0A)
0.75A 2x0yA-2j4gA:
41.7
2x0yA-2j4gA:
32.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2j4g HYALURONOGLUCOSAMINI
DASE


(Bacteroides
thetaiotaomicron)
PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase)
7 LYS A 166
VAL A 314
TRP A 337
ASN A 339
VAL A 342
ASP A 344
ASN A 372
NB1  A1590 (-3.0A)
None
NB1  A1590 (-3.7A)
NB1  A1590 (-3.6A)
NB1  A1590 ( 4.9A)
NB1  A1590 ( 3.0A)
NB1  A1590 (-3.4A)
0.84A 2x0yA-2j4gA:
41.7
2x0yA-2j4gA:
32.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2j4g HYALURONOGLUCOSAMINI
DASE


(Bacteroides
thetaiotaomicron)
PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase)
8 TYR A 282
THR A 310
VAL A 314
TRP A 337
ASN A 339
VAL A 342
ASP A 344
ASN A 372
NB1  A1590 (-3.8A)
NB1  A1590 (-3.9A)
None
NB1  A1590 (-3.7A)
NB1  A1590 (-3.6A)
NB1  A1590 ( 4.9A)
NB1  A1590 ( 3.0A)
NB1  A1590 (-3.4A)
0.49A 2x0yA-2j4gA:
41.7
2x0yA-2j4gA:
32.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2v5d O-GLCNACASE NAGJ

(Clostridium
perfringens)
PF00754
(F5_F8_type_C)
PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase)
5 LYS A 218
TYR A 295
ASP A 297
VAL A 331
TYR A 335
None
1.17A 2x0yA-2v5dA:
52.0
2x0yA-2v5dA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2v5d O-GLCNACASE NAGJ

(Clostridium
perfringens)
PF00754
(F5_F8_type_C)
PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase)
11 LYS A 218
TYR A 295
VAL A 331
TYR A 335
THR A 366
VAL A 370
TRP A 394
ASN A 396
VAL A 399
ASP A 401
ASN A 429
None
0.58A 2x0yA-2v5dA:
52.0
2x0yA-2v5dA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xhy 6-PHOSPHO-BETA-GLUCO
SIDASE BGLA


(Escherichia
coli)
PF00232
(Glyco_hydro_1)
5 TYR A 194
VAL A 200
TYR A 201
VAL A 214
VAL A 153
None
1.46A 2x0yA-2xhyA:
14.5
2x0yA-2xhyA:
21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xsb HYALURONOGLUCOSAMINI
DASE


(Oceanicola
granulosus)
PF07555
(NAGidase)
8 LYS A  39
ASP A 115
TYR A 160
THR A 191
TRP A 219
ASN A 221
ASP A 226
ASN A 254
GDL  A1436 ( 3.8A)
None
GDL  A1436 (-3.6A)
GDL  A1436 ( 4.5A)
GDL  A1436 (-3.6A)
GDL  A1436 (-3.0A)
GDL  A1436 (-3.0A)
GDL  A1436 (-3.4A)
0.42A 2x0yA-2xsbA:
38.6
2x0yA-2xsbA:
21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z2f LYSOZYME C-2

(Bos taurus)
PF00062
(Lys)
5 ASP A 117
VAL A 120
TRP A 111
ASN A  27
VAL A  23
None
1.28A 2x0yA-2z2fA:
undetectable
2x0yA-2z2fA:
12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c7k GUANINE
NUCLEOTIDE-BINDING
PROTEIN G(O) SUBUNIT
ALPHA


(Mus musculus)
PF00503
(G-alpha)
5 LYS A  51
TYR A  69
VAL A  72
VAL A 186
ASP A 201
GDP  A 361 ( 4.5A)
None
None
None
MG  A 362 ( 4.5A)
1.41A 2x0yA-3c7kA:
3.2
2x0yA-3c7kA:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3igr RIBOSOMAL-PROTEIN-S5
-ALANINE
N-ACETYLTRANSFERASE


(Aliivibrio
fischeri)
PF13302
(Acetyltransf_3)
5 TYR A  86
VAL A  84
TYR A 101
VAL A 147
ASN A 118
None
None
None
None
NA  A 185 (-4.4A)
1.33A 2x0yA-3igrA:
undetectable
2x0yA-3igrA:
14.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kxw SAFRAMYCIN MX1
SYNTHETASE B


(Legionella
pneumophila)
PF00501
(AMP-binding)
5 ASP A 440
VAL A 451
THR A 335
VAL A 334
ASP A 218
1ZZ  A 589 (-2.8A)
1ZZ  A 589 (-4.4A)
None
None
1ZZ  A 589 (-2.5A)
0.97A 2x0yA-3kxwA:
undetectable
2x0yA-3kxwA:
21.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nz4 PHENYLALANINE
AMMONIA-LYASE


(Taxus
canadensis)
PF00221
(Lyase_aromatic)
5 THR A 141
VAL A  29
ASN A 138
VAL A 349
ASN A 350
None
1.43A 2x0yA-3nz4A:
3.0
2x0yA-3nz4A:
22.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fhn NUCLEOPORIN NUP120

(Schizosaccharomyces
pombe)
PF11715
(Nup160)
5 ASP B 525
VAL B 530
TYR B 532
VAL B  88
ASN B  91
None
1.50A 2x0yA-4fhnB:
undetectable
2x0yA-4fhnB:
19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ksi LEUCINE
AMINOPEPTIDASE 1,
CHLOROPLASTIC


(Solanum
lycopersicum)
PF00883
(Peptidase_M17)
PF02789
(Peptidase_M17_N)
5 ASP A 347
THR A 433
VAL A 310
VAL A 423
ASN A 514
MG  A 601 ( 2.5A)
None
None
None
None
1.31A 2x0yA-4ksiA:
2.4
2x0yA-4ksiA:
23.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4phs PUTATIVE
GLYCOSYLTRANSFERASE
(GALT1)


(Streptococcus
parasanguinis)
PF08759
(GT-D)
5 ASP A 181
TYR A 180
THR A 203
VAL A 206
ASN A  48
None
1.38A 2x0yA-4phsA:
undetectable
2x0yA-4phsA:
18.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yb9 SOLUTE CARRIER
FAMILY 2,
FACILITATED GLUCOSE
TRANSPORTER MEMBER 5


(Bos taurus)
PF00083
(Sugar_tr)
5 VAL D 164
THR D 171
VAL D 326
ASN D 325
VAL D 384
None
1.46A 2x0yA-4yb9D:
2.4
2x0yA-4yb9D:
21.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zxl O-GLCNACASE NAGJ

(Clostridium
perfringens)
PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase)
6 LYS A 218
TYR A 295
ASN A 396
VAL A 399
ASP A 401
ASN A 429
None
0.92A 2x0yA-4zxlA:
54.3
2x0yA-4zxlA:
99.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zxl O-GLCNACASE NAGJ

(Clostridium
perfringens)
PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase)
10 TYR A 295
ASP A 297
VAL A 331
TYR A 335
THR A 366
VAL A 370
ASN A 396
VAL A 399
ASP A 401
ASN A 429
None
0.61A 2x0yA-4zxlA:
54.3
2x0yA-4zxlA:
99.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zxl O-GLCNACASE NAGJ

(Clostridium
perfringens)
PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase)
10 TYR A 295
VAL A 331
TYR A 335
THR A 366
VAL A 370
TRP A 394
ASN A 396
VAL A 399
ASP A 401
ASN A 429
None
0.48A 2x0yA-4zxlA:
54.3
2x0yA-4zxlA:
99.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5diy HYALURONIDASE

(Thermobaculum
terrenum)
PF07555
(NAGidase)
8 ASP A 119
TYR A 168
THR A 193
VAL A 197
ASN A 223
VAL A 226
ASP A 228
ASN A 257
None
0.63A 2x0yA-5diyA:
41.7
2x0yA-5diyA:
24.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5diy HYALURONIDASE

(Thermobaculum
terrenum)
PF07555
(NAGidase)
8 TYR A 168
THR A 193
VAL A 197
TRP A 221
ASN A 223
VAL A 226
ASP A 228
ASN A 257
None
0.47A 2x0yA-5diyA:
41.7
2x0yA-5diyA:
24.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gjw VOLTAGE-DEPENDENT
CALCIUM CHANNEL
SUBUNIT
ALPHA-2/DELTA-1


(Oryctolagus
cuniculus)
PF00092
(VWA)
PF08399
(VWA_N)
PF08473
(VGCC_alpha2)
5 ASP F 454
VAL F 461
TYR F 452
THR F 449
VAL F 489
None
1.24A 2x0yA-5gjwF:
undetectable
2x0yA-5gjwF:
19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gzs GGDEF FAMILY PROTEIN

(Vibrio cholerae)
PF00497
(SBP_bac_3)
5 TYR A 148
ASP A 184
VAL A 183
TYR A 127
ASN A 203
ARG  A 501 (-4.1A)
ARG  A 501 ( 4.9A)
None
None
None
1.43A 2x0yA-5gzsA:
undetectable
2x0yA-5gzsA:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m7r PROTEIN O-GLCNACASE

(Homo sapiens)
PF07555
(NAGidase)
6 ASP A 174
TYR A 219
THR A 250
VAL A 254
ASN A 280
ASP A 285
None
0.81A 2x0yA-5m7rA:
39.0
2x0yA-5m7rA:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m7r PROTEIN O-GLCNACASE

(Homo sapiens)
PF07555
(NAGidase)
7 TYR A 219
THR A 250
VAL A 254
TRP A 278
ASN A 280
ASP A 285
ASN A 313
None
0.46A 2x0yA-5m7rA:
39.0
2x0yA-5m7rA:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uhk O-GLCNACASE
TIM-BARREL DOMAIN


(Homo sapiens)
PF07555
(NAGidase)
9 LYS A  98
ASP A 174
TYR A 219
THR A 250
VAL A 254
TRP A 278
ASN A 280
ASP A 285
ASN A 313
GOL  A 502 (-4.0A)
GOL  A 501 (-3.1A)
GOL  A 501 (-3.3A)
GOL  A 501 (-4.4A)
None
GOL  A 501 (-3.6A)
GOL  A 501 (-3.4A)
GOL  A 502 (-2.9A)
GOL  A 502 (-3.4A)
0.73A 2x0yA-5uhkA:
37.4
2x0yA-5uhkA:
24.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uhp O-GLCNACASE
TIM-BARREL DOMAIN


(Homo sapiens)
PF07555
(NAGidase)
8 ASP A 174
TYR A 219
THR A 250
VAL A 254
TRP A 278
ASN A 280
ASP A 285
ASN A 313
GOL  A 501 (-2.5A)
GOL  A 501 (-3.7A)
GOL  A 501 (-4.2A)
GOL  A 501 (-4.2A)
GOL  A 501 (-3.8A)
GOL  A 501 (-3.4A)
None
None
0.54A 2x0yA-5uhpA:
36.5
2x0yA-5uhpA:
29.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vvo PROTEIN O-GLCNACASE

(Homo sapiens)
PF07555
(NAGidase)
6 ASP A 174
TYR A 219
VAL A 254
ASN A 280
ASP A 285
ASN A 313
None
0.79A 2x0yA-5vvoA:
38.7
2x0yA-5vvoA:
25.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vvo PROTEIN O-GLCNACASE

(Homo sapiens)
PF07555
(NAGidase)
7 TYR A 219
THR A 250
VAL A 254
TRP A 278
ASN A 280
ASP A 285
ASN A 313
None
0.40A 2x0yA-5vvoA:
38.7
2x0yA-5vvoA:
25.73